Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24


Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer.

Tang Y, Qiao G, Xu E, Xuan Y, Liao M, Yin G.

Onco Targets Ther. 2017 Sep 12;10:4527-4534. doi: 10.2147/OTT.S142149. eCollection 2017. Review.


Helping Health Care Providers and Clinical Scientists Understand Apparently Irrational Policy Decisions.

Demeter SJ.

Cureus. 2016 Dec 21;8(12):e936. doi: 10.7759/cureus.936. Review.


Procedures for risk-stratification of lung cancer using buccal nanocytology.

Subramanian H, Viswanathan P, Cherkezyan L, Iyengar R, Rozhok S, Verleye M, Derbas J, Czarnecki J, Roy HK, Backman V.

Biomed Opt Express. 2016 Aug 31;7(9):3795-3810. eCollection 2016 Sep 1.


Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules.

Liu Y, Balagurunathan Y, Atwater T, Antic S, Li Q, Walker RC, Smith GT, Massion PP, Schabath MB, Gillies RJ.

Clin Cancer Res. 2017 Mar 15;23(6):1442-1449. doi: 10.1158/1078-0432.CCR-15-3102. Epub 2016 Sep 23.


The Effect of False-Positive Results on Subsequent Participation in Chest X-ray Screening for Lung Cancer.

Sato A, Hamada S, Urashima Y, Tanaka S, Okamoto H, Kawakami K.

J Epidemiol. 2016 Dec 5;26(12):646-653. Epub 2016 Jul 2.


Tobacco smoking and methylation of genes related to lung cancer development.

Gao X, Zhang Y, Breitling LP, Brenner H.

Oncotarget. 2016 Sep 13;7(37):59017-59028. doi: 10.18632/oncotarget.10007.


Lung cancer screening: Computed tomography or chest radiographs?

van Beek EJ, Mirsadraee S, Murchison JT.

World J Radiol. 2015 Aug 28;7(8):189-93. doi: 10.4329/wjr.v7.i8.189.


Comparison of tumor markers using different detection devices.

Tao R, Tu S, Liu C, Yang Q, Zhu M, Shen J.

Onco Targets Ther. 2015 May 19;8:1083-90. doi: 10.2147/OTT.S79109. eCollection 2015. Retraction in: Onco Targets Ther. 2016;9:4255.


Screening tests: a review with examples.

Maxim LD, Niebo R, Utell MJ.

Inhal Toxicol. 2014 Nov;26(13):811-28. doi: 10.3109/08958378.2014.955932. Epub 2014 Sep 29. Review.


Screening for lung cancer.

Kennedy S, Baerlocher MO.

CMAJ. 2014 May 13;186(8):E296. doi: 10.1503/cmaj.131385. Epub 2014 Mar 17. Review. No abstract available.


Low-dose CT scan screening for lung cancer: comparison of images and radiation doses between low-dose CT and follow-up standard diagnostic CT.

Ono K, Hiraoka T, Ono A, Komatsu E, Shigenaga T, Takaki H, Maeda T, Ogusu H, Yoshida S, Fukushima K, Kai M.

Springerplus. 2013 Aug 21;2:393. doi: 10.1186/2193-1801-2-393. eCollection 2013.


Probability of cancer in pulmonary nodules detected on first screening CT.

McWilliams A, Tammemagi MC, Mayo JR, Roberts H, Liu G, Soghrati K, Yasufuku K, Martel S, Laberge F, Gingras M, Atkar-Khattra S, Berg CD, Evans K, Finley R, Yee J, English J, Nasute P, Goffin J, Puksa S, Stewart L, Tsai S, Johnston MR, Manos D, Nicholas G, Goss GD, Seely JM, Amjadi K, Tremblay A, Burrowes P, MacEachern P, Bhatia R, Tsao MS, Lam S.

N Engl J Med. 2013 Sep 5;369(10):910-9. doi: 10.1056/NEJMoa1214726.


Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.

Goulart BH, Ramsey SD.

Oncologist. 2013;18(8):941-6. doi: 10.1634/theoncologist.2013-0007. Epub 2013 Jul 19.


Update in lung cancer and mesothelioma 2012.

Powell CA, Halmos B, Nana-Sinkam SP.

Am J Respir Crit Care Med. 2013 Jul 15;188(2):157-66. doi: 10.1164/rccm.201304-0716UP. Review. No abstract available.


CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort.

Greenberg AK, Lu F, Goldberg JD, Eylers E, Tsay JC, Yie TA, Naidich D, McGuinness G, Pass H, Tchou-Wong KM, Addrizzo-Harris D, Chachoua A, Crawford B, Rom WN.

PLoS One. 2012;7(7):e39403. doi: 10.1371/journal.pone.0039403. Epub 2012 Jul 2.


Screening for cancer with molecular markers: progress comes with potential problems.

Baron JA.

Nat Rev Cancer. 2012 Apr 12;12(5):368-71. doi: 10.1038/nrc3260. Review.


A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening.

Bigbee WL, Gopalakrishnan V, Weissfeld JL, Wilson DO, Dacic S, Lokshin AE, Siegfried JM.

J Thorac Oncol. 2012 Apr;7(4):698-708. doi: 10.1097/JTO.0b013e31824ab6b0.


Lung cancer screening practices of primary care physicians: results from a national survey.

Klabunde CN, Marcus PM, Han PK, Richards TB, Vernon SW, Yuan G, Silvestri GA.

Ann Fam Med. 2012 Mar-Apr;10(2):102-10. doi: 10.1370/afm.1340.


Early lung cancer detection using the self-evaluation scoring questionnaire and chest digital radiography: a 3-year follow-up study in China.

Chen B, Wang Y, Cao H, Liu D, Zhang S, Gao J, Yu J, Huang Y, Li W.

J Digit Imaging. 2013 Feb;26(1):72-81. doi: 10.1007/s10278-012-9468-4.


The use and misuse of positron emission tomography in lung cancer evaluation.

Chang CF, Rashtian A, Gould MK.

Clin Chest Med. 2011 Dec;32(4):749-62. doi: 10.1016/j.ccm.2011.08.012. Review.

Supplemental Content

Support Center